Unit counts land on clean numbers
Disclosures: Loghman Salimzadeh: Nothing to Disclose, Stuti Shah: Nothing to Disclose, Danie La: Nothing to Disclose, Hilario Ramos: Bluejay Therapeutics: Employee, Bluejay Therapeutics: Stock privately held company, Nancy Shulman: Bluejay Therapeutics, INC: Salary and equity, Hassan Javanbakht: Nothing to Disclose, Adam Gehring: Nothing to Disclose 452 PRECLINICAL PHARMACOKINETICS OF EDP-514, AN ORAL, ONCE-DAILY ANTIVIRAL TREATMENT FOR HEPATITIS B VIRUS Meng Huang 1 Khanh Hoang 1 Jonathan Kibel 1 Shucha Zhang 1 Lisha Xu 1 Yang Li 1 Indy Zang 1 Daniel Leonard 1 Siu-Lung Chan 1 Joshua Klaene 1 Yat Sun Or 1 Li-Juan Jiang 1 , 1 Enanta Pharmaceuticals Background: Hepatitis B virus (HBV) is a global public health threat that causes approximately 1.5 million new infections every year
6) Utility of gene testing kits for preoperative diagnosis of follicular tumors The preoperative diagnosis of follicular tumors has presented a longstanding challenge
Nicholas Perricone, one of the first to use neuropeptides in topical skincare for their high-performing benefits
Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients
RNA isolation and analysis The leaf samples were frozen in liquid nitrogen and ground in a mortar, followed by RNA extraction using the innuPREP Plant RNA Kit (Analytik Jena, Jena, Germany) according to the kit instructions